Sangamo joins biotech migration to Oyster Point with new HQ
Joining the flock of biotechs headed to Oyster Point, gene therapy company Sangamo Therapeutics is building a new headquarters and manufacturing facility in the Bay …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.